Please login to the form below

Why are doctors frustrated with the digitalisation of healthcare?

In this article, Customer Experience Consultant Anna Tamasi from Blue Latitude Health highlights the most common usability and user experience implications that the digitalisation of healthcare poses on doctors professional lives.
Today, everything we do is done on a digital device; we attach devices to our bodies, we equip our homes with smart devices, we pay with our phones, we speak to our doctor over Skype, we diagnose ourselves using a mobile health app. When a new technology comes out, we simply adapt. And we can adapt because we have a choice about whether we’ll use it or not – there is no one making us use particular apps or devices.  

In healthcare, it’s different. It’s not a consumer-driven market where we can assume that patient-centred innovations will automatically influence adoption within doctor communities. Pharma companies should consider the challenges doctors face with new technology if they want to make a positive impact on the lives of their customers.  

In this article, Customer Experience Consultant Anna Tamasi highlights the most common usability and user experience implications that the digitalisation of healthcare poses on doctors professional lives.

Processes that do not consider adoption models

With the low number of healthcare workers available for our growing needs, healthcare remains a suppliers' market where primary care computing suppliers have a significant effect on the delivery of information and information systems.  

We normally assume that doctors are happily using digital tools and willing to receive data feeds from their patients or engage with digital services. But for doctors to embrace new ways and new tools of clinical care, new technology implementations have to hold a clear value proposition.

Download the full article from Blue Latitude Health here

17th February 2016



Company Details

Blue Latitude Health

+44 203 328 1840

Contact Website

Blue Latitude Health
Crusader House
145-157 St John Street
United Kingdom

Latest content on this profile

Big data, privacy and the rise of genomic testing
Blue Latitude Health speaks to Johan Christiaanse, Marketing Director at BGI, to find out how the medical profession can overcome one of the major barriers to precision medicine – big data.
Blue Latitude Health
Lynch syndrome: a patient perspective
Blue Latitude Health intern Costantino Ciotti gives an insight into life with Lynch Syndrome, a genetic condition associated with colon cancer. Here he explores the patient’s perspective, including treatment options, and gives his advice for healthcare professionals diagnosing patients with a genetic disease.
Blue Latitude Health
What does programmatic advertising mean for your pharma marketing strategy?
Senior Associate Consultant Jiayi Chen explains the benefits and pitfalls of programmatic advertising and reveals how it can impact return on investment in your marketing campaigns.
Blue Latitude Health
How to measure marketing success: profit vs ROI
Measuring marketing activity is proving to be a major challenge in pharma. Here, Senior Consultant Paul Townley-Jones explores the meaning of success and gives his tips for measuring efficiency and effectiveness, along with the formula for calculating profit and ROI.
Blue Latitude Health
Perspective on biotech leaders
In the latest issue of Perspective magazine, seven industry trailblazers reveal the trends, challenges and opportunities they anticipate in the biotech sector, from empowering patients to deciphering big data.
Blue Latitude Health
Global customer research in healthcare: 10 tips for capturing insights that matter
What makes a strong brand? One global core coupled with sensitivity to regions and countries. In part two of our series on customer insight and behaviour change, we share our tips on optimising global customer research projects to ensure you get the balance right in an efficient way.
Blue Latitude Health